Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Launched by UNC LINEBERGER COMPREHENSIVE CANCER CENTER · Jun 3, 2010
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on collecting and storing samples of blood, tissue, and body fluids from patients who have been diagnosed with certain types of blood cancers, such as leukemia, lymphoma, and multiple myeloma. The goal is to use these samples for laboratory research, which may help scientists better understand these cancers and improve future treatments. If you are currently being evaluated for a blood cancer at the University of North Carolina Hospitals, you might be eligible to participate in this study.
Participants can expect to provide blood and tissue samples during their visits to the hematology or oncology clinics. The trial is open to individuals of various ages who have been diagnosed with specific hematologic conditions. By joining this study, patients will contribute to important research that could benefit others with blood cancers in the future. If you're interested, it’s a great opportunity to help advance cancer research!
Gender
ALL
Eligibility criteria
- DISEASE CHARACTERISTICS:
- * Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following:
- • Acute myeloid leukemia
- • Acute lymphoblastic leukemia
- • Chronic myelogenous leukemia
- • Chronic lymphoid leukemia
- • Non-Hodgkin lymphoma
- • Hodgkin lymphoma
- • Myelodysplastic syndromes
- • Myeloproliferative disorders
- • Multiple myeloma
- • Waldenstrom macroglobulinemia
- • Aplastic anemia
- • Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage
- • Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital
- PATIENT CHARACTERISTICS:
- • Not specified
- PRIOR CONCURRENT THERAPY:
- • Not specified
About Unc Lineberger Comprehensive Cancer Center
The UNC Lineberger Comprehensive Cancer Center is a leading research institution dedicated to advancing cancer treatment and prevention through innovative clinical trials and comprehensive patient care. As a National Cancer Institute-designated comprehensive cancer center, it integrates cutting-edge research, interdisciplinary collaboration, and patient-centered approaches to address diverse oncology challenges. With a commitment to translating scientific discoveries into effective therapies, UNC Lineberger strives to improve outcomes for patients while fostering a robust environment for education and training in cancer research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Paul Armistead, MD
Principal Investigator
UNC Lineberger Comprehensive Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials